Feng Zhou

发表

Design of novel Xenopus GLP-1-based dual glucagon-like peptide 1 (GLP-1)/glucagon receptor agonists.

Weizhong Tang, Jing Han, Xinyu Chen, 2020, European journal of medicinal chemistry.

Glucagon-like peptide-1 loaded phospholipid micelles for the treatment of type 2 diabetes: improved pharmacokinetic behaviours and prolonged glucose-lowering effects

Junjie Fu, Yan Tang, Xiaoke Gu, 2016 .

Lithocholic Acid-Based Peptide Delivery System for an Enhanced Pharmacological and Pharmacokinetic Profile of Xenopus GLP-1 Analogs.

Jing Han, Junjie Fu, Xinyu Chen, 2018, Molecular pharmaceutics.

Dipeptidyl Peptidase 4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus: Focus on Efficacy, Disposition and Safety

Tianxin Yang, Feng Zhou, Zhi-xu He, 2015 .

Design of Xenopus GLP-1-Based Long-Acting Dual GLP-1/Y2 Receptor Agonists.

Weizhong Tang, Jing Han, Yongliang Yuan, 2022, Journal of medicinal chemistry.

Discovery of once-weekly, peptide-based selective GLP-1 and cholecystokinin 2 receptors co-agonizts

Jing Han, Qimeng Yang, Feng Zhou, 2022, Peptides.

Stapled and Xenopus Glucagon-Like Peptide 1 (GLP-1)-Based Dual GLP-1/Gastrin Receptor Agonists with Improved Metabolic Benefits in Rodent Models of Obesity and Diabetes.

Wen Jiang, Jian Yin, Jing Han, 2020, Journal of medicinal chemistry.

Peptide-based long-acting co-agonists of GLP-1 and cholecystokinin 1 receptors as novel anti-diabesity agents.

Wen Jiang, Jing Han, Yongliang Yuan, 2022, European journal of medicinal chemistry.

Micellar Nanomedicine of Novel Fatty Acid Modified Xenopus Glucagon-like Peptide-1: Improved Physicochemical Characteristics and Therapeutic Utilities for Type 2 Diabetes.

Jing Han, Junjie Fu, Xinyu Chen, 2017, Molecular pharmaceutics.

Stapled, Long-Acting Xenopus GLP-1-Based Dual GLP-1/Glucagon Receptor Agonists with Potent Therapeutic Efficacy for Metabolic Disease.

Lintao Wu, Chun Han, Jing Han, 2021, Molecular pharmaceutics.

Xenopus‐derived glucagon‐like peptide‐1 and polyethylene‐glycosylated glucagon‐like peptide‐1 receptor agonists: long‐acting hypoglycaemic and insulinotropic activities with potential therapeutic utilities

Jing Han, Junjie Fu, Xinyu Chen, 2017, British journal of pharmacology.

Xenopus GLP‐1‐inspired discovery of novel GLP‐1 receptor agonists as long‐acting hypoglycemic and insulinotropic agents with significant therapeutic potential

Jing Han, Junjie Fu, Xinyu Chen, 2017, Biochemical pharmacology.

The chronic administration of two novel long‐acting Xenopus glucagon‐like peptide‐1 analogs xGLP159 and XGLP296 potently improved systemic metabolism and glycemic control in rodent models

Tingting Meng, Jing Han, Junjie Fu, 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Rational design of dimeric lipidated Xenopus glucagon-like peptide 1 analogues as long-acting antihyperglycaemic agents.

Yue Huang, Jing Han, Junjie Fu, 2018, European journal of medicinal chemistry.

Lipidation and conformational constraining for prolonging the effects of peptides: Xenopus glucagon‐like peptide 1 analogues with potent and long‐acting hypoglycemic activity

Yue Huang, Jing Han, Junjie Fu, 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Discovery of once-weekly, peptide-based selective GLP-1 and cholecystokinin 2 receptors co-agonizts

Jing Han, Qimeng Yang, Feng Zhou, 2022, Peptides.

Design, synthesis and biological evaluation of PEGylated Xenopus glucagon-like peptide-1 derivatives as long-acting hypoglycemic agents.

Jing Han, Junjie Fu, Yingying Fei, 2017, European journal of medicinal chemistry.